| 2024 |
Schwarz, E. M., Archer, N. K., Atkins, G. J., Bentley, K. L. D. M., Botros, M., Cassat, J. E., . . . Xie, C. (2024). The 2023 Orthopaedic Research Society's International Consensus Meeting on musculoskeletal infection: Summary from the host immunity section. Journal of Orthopaedic Research, 42(3), 518-530.
DOI Scopus5 |
| 2024 |
Hickok, N. J., Li, B., Oral, E., Zaat, S. A. J., Armbruster, D. A., Atkins, G. J., . . . Zinkernagel, A. S. (2024). The 2023 Orthopedic Research Society's international consensus meeting on musculoskeletal infection: Summary from the in vitro section. Journal of Orthopaedic Research, 42(3), 512-517.
DOI Scopus8 Europe PMC2 |
| 2024 |
Muratovic, D., Atkins, G. J., & Findlay, D. M. (2024). Is RANKL a potential molecular target in osteoarthritis?. Osteoarthritis and Cartilage, 32(5), 493-500.
DOI Scopus5 Europe PMC2 |
| 2024 |
Bhanushali, A., Tran, L., Nairne-Nagy, J., Bereza, S., Callary, S. A., Atkins, G. J., . . . Solomon, L. B. (2024). Patient-Related Predictors of Treatment Failure After Two-Stage Total Hip Arthroplasty Revision for Periprosthetic Joint Infection: A Systematic Review and Meta-Analysis. Journal of Arthroplasty, 39(9), 2395-2402.e14.
DOI |
| 2024 |
Gunn, N. J., Kidd, S. P., Solomon, L. B., Yang, D., Roscioli, E., & Atkins, G. J. (2024). Staphylococcus aureus persistence in osteocytes: weathering the storm of antibiotics and autophagy/xenophagy. Frontiers in Cellular and Infection Microbiology, 14, 1403289-1-1403289-13.
DOI |
| 2024 |
Sun, Q., Huynh, K., Muratovic, D., Gunn, N. J., Zelmer, A. R., Solomon, L. B., . . . Yang, D. (2024). Rapid bacterial evaluation beyond the colony forming unit in osteomyelitis. eLife, 13, RP93698-1-RP93698-11.
DOI |
| 2024 |
Zelmer, A. R., Yang, D., Gunn, N. J., Solomon, L. B., Nelson, R., Kidd, S. P., . . . Atkins, G. J. (2024). Osteomyelitis-relevant antibiotics at clinical concentrations show limited effectivity against acute and chronic intracellular <i>S. aureus</i> infections in osteocytes. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 14 pages.
DOI |
| 2023 |
Sung, J., Barratt, K. R., Pederson, S. M., Chenu, C., Reichert, I., Atkins, G. J., . . . Smitham, P. J. (2023). Unbiased gene expression analysis of the delayed fracture healing observed in Zucker diabetic fatty rats. Bone and Joint Research, 12(10), 657-666.
DOI |
| 2023 |
Zelmer, A. R., Starczak, Y., Solomon, L. B., Richter, K., Yang, D., & Atkins, G. J. (2023). Saos-2 cells cultured under hypoxia rapidly differentiate to an osteocyte-like stage and support intracellular infection by Staphylococcus aureus.. Physiol Rep, 11(21), e15851-1-e15851-12.
DOI Europe PMC1 |
| 2023 |
Zelmer, A., Starczak, Y., Solomon, L., Richter, K., Yang, D., & Atkins, G. (2023). Culture of Saos-2 cells under hypoxic conditions stimulates rapid differentiation to an osteocyte-like stage.
DOI |
| 2023 |
Muratovic, D., Findlay, D. M., Quinn, M. J., Quarrington, R. D., Solomon, L. B., & Atkins, G. J. (2023). Microstructural and cellular characterisation of the subchondral trabecular bone in human knee and hip osteoarthritis using synchrotron tomography. Osteoarthritis and Cartilage, 31(9), 1224-1233.
DOI Scopus4 WoS1 |
| 2022 |
Ormsby, R. T., Hosaka, K., Evdokiou, A., Odysseos, A., Findlay, D. M., Solomon, L. B., & Atkins, G. J. (2022). The Effects of Vitamin E Analogues α-Tocopherol and γ-Tocotrienol on the Human Osteocyte Response to Ultra-High Molecular Weight Polyethylene Wear Particles. Prosthesis, 4(3), 480-489.
DOI Scopus2 WoS1 |
| 2022 |
Kitchen, D. S., Richards, J., Smitham, P. J., Atkins, G. J., & Solomon, L. B. (2022). Does time to theatre affect the ability to achieve fracture reduction in tibial plateau fractures?. Journal of Clinical Medicine, 11(1), 1-13.
DOI Scopus3 WoS3 Europe PMC1 |
| 2022 |
Day, C. W., Costi, K., Pannach, S., Atkins, G. J., Hofstaetter, J. G., Callary, S. A., . . . Solomon, L. B. (2022). Long-term outcomes of staged revision surgery for chronic periprosthetic joint infection of total hip arthroplasty. Journal of Clinical Medicine, 11(1), 1-14.
DOI Scopus12 WoS3 Europe PMC7 |
| 2022 |
Bennett, K. J., Pizzolato, C., Martelli, S., Bahl, J. S., Sivakumar, A., Atkins, G. J., . . . Thewlis, D. (2022). EMG-informed neuromusculoskeletal models accurately predict knee loading measured using instrumented implants. IEEE Transactions on Biomedical Engineering, 69(7), 2268-2275.
DOI Scopus27 WoS17 Europe PMC6 |
| 2022 |
Bliuc, D., Tran, T., Adachi, J. D., Atkins, G. J., Berger, C., van den Bergh, J., . . . CaMos Research Group. (2022). The association between cognitive decline and bone loss and fracture risk is not affected by medication with anticholinergic effect.. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 37(5), 1075-1076.
DOI |
| 2022 |
Muratovic, D., Findlay, D. M., Quarrington, R. D., Cao, X., Solomon, L. B., Atkins, G. J., & Kuliwaba, J. S. (2022). Elevated levels of active Transforming Growth Factor β1 in the subchondral bone relate spatially to cartilage loss and impaired bone quality in human knee osteoarthritis. Osteoarthritis and Cartilage, 30(6), 896-907.
DOI Scopus7 WoS1 Europe PMC2 |
| 2022 |
Ormsby, R., Hosaka, K., Evdokiou, A., Odysseos, A., Findlay, D., Solomon, L., & Atkins, G. (2022). The Effects of Vitamin E Analogues α-Tocopherol and γ-Tocotrienol on the Human Osteocyte Response to Ultra-high Molecular Weight Polyethylene Wear Particles.
DOI |
| 2022 |
Hofstaetter, J. G., Atkins, G. J., Kato, H., Kogawa, M., Blouin, S., Misof, B. M., . . . Ito, N. (2022). A Mild Case of Autosomal Recessive Osteopetrosis Masquerading as the Dominant Form Involving Homozygous Deep Intronic Variations in the CLCN7 Gene. Calcified Tissue International, 111(4), 430-444.
DOI Scopus2 WoS1 Europe PMC2 |
| 2022 |
Grace, T. M., Solomon, L. B., Atkins, G. J., Thewlis, D., & Taylor, M. (2022). Assigning trabecular bone material properties in finite element models simulating the pelvis before and after the development of peri-prosthetic osteolytic lesions. Journal of the Mechanical Behavior of Biomedical Materials, 133, 1-13.
DOI Scopus1 |
| 2022 |
Alshabrawy, A. K., Cui, Y., Sylvester, C., Yang, D., Petito, E. S., Barratt, K. R., . . . Anderson, P. H. (2022). Therapeutic Potential of a Novel Vitamin D3 Oxime Analogue, VD1-6, with CYP24A1 Enzyme Inhibitory Activity and Negligible Vitamin D Receptor Binding. Biomolecules, 12(7), 1-14.
DOI Scopus5 WoS3 Europe PMC4 |
| 2022 |
Zelmer, A. R., Nelson, R., Richter, K., & Atkins, G. J. (2022). Can intracellular Staphylococcus aureus in osteomyelitis be treated using current antibiotics? A systematic review and narrative synthesis. Bone Research, 10(53), 1-18.
DOI Scopus37 WoS18 Europe PMC24 |
| 2022 |
Bennett, K. J., Callary, S. A., Atkins, G. J., Martelli, S., Perilli, E., Bogdan Solomon, L., & Thewlis, D. (2022). Ex vivo assessment of surgically repaired tibial plateau fracture displacement under axial load using large-volume micro-CT. Journal of Biomechanics, 144, 111275-1-111275-10.
DOI Scopus2 Europe PMC1 |
| 2021 |
Stapledon, C. J. M., Stamenkov, R., Cappai, R., Clark, J. M., Bourke, A., Bogdan Solomon, L., & Atkins, G. J. (2021). Relationships between the bone expression of Alzheimer's disease-related genes, bone remodelling genes and cortical bone structure in neck of femur fracture. Calcified Tissue International, 108(5), 610-621.
DOI Scopus9 WoS5 Europe PMC4 |
| 2021 |
Maher, S., Wijenayaka, A. R., Lima-Marques, L., Yang, D., Atkins, G. J., & Losic, D. (2021). Advancing of Additive-Manufactured Titanium Implants with Bioinspired Micro- to Nanotopographies. ACS Biomaterials Science & Engineering, 7(2), 441-450.
DOI Scopus31 WoS22 Europe PMC11 |
| 2021 |
Bliuc, D., Tran, T., Adachi, J. D., Atkins, G. J., Berger, C., van den Bergh, J., . . . Canadian Multicentre Osteoporosis Study (CaMos) Research Group. (2021). Cognitive decline is associated with an accelerated rate of bone loss and increased fracture risk in women: a prospective study from the Canadian Multicentre Osteoporosis Study. Journal of Bone and Mineral Research, 36(11), 2106-2115.
DOI Scopus20 WoS8 Europe PMC14 |
| 2021 |
Edwards, D. F., Miller, C. J., Quintana‐Martinez, A., Wright, C. S., Prideaux, M., Atkins, G. J., . . . Clinkenbeard, E. L. (2021). Differential iron requirements for osteoblast and adipocyte differentiation. JBMR Plus, 5(9), e10529-1-e10529-11.
DOI Scopus8 WoS5 Europe PMC5 |
| 2021 |
Barratt, K. R., Sawyer, R. K., Atkins, G. J., St-Arnaud, R., & Anderson, P. H. (2021). Vitamin D supplementation improves bone mineralisation independent of dietary phosphate in male X-linked hypophosphatemic (Hyp) mice. Bone, 143, 115767-1-115767-9.
DOI Scopus8 WoS5 Europe PMC5 |
| 2021 |
Ito, N., Prideaux, M., Wijenayaka, A. R., Yang, D., Ormsby, R. T., Bonewald, L. F., & Atkins, G. J. (2021). Sclerostin directly stimulates osteocyte aynthesis of fibroblast growth factor-23. Calcified Tissue International, 109(1), 66-76.
DOI Scopus31 WoS21 Europe PMC24 |
| 2021 |
Noonan, M. L., Ni, P., Agoro, R., Sacks, S. A., Swallow, E. A., Wheeler, J. A., . . . White, K. E. (2021). The HIF-PHI BAY 85-3934 (Molidustat) improves anemia and is associated with reduced levels of circulating FGF23 in a CKD mouse model.. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 36(6), 1117-1130.
DOI Scopus19 WoS17 Europe PMC15 |
| 2021 |
Tippen, S. P., Noonan, M. L., Ni, P., Metzger, C. E., Swallow, E. A., Sacks, S. A., . . . White, K. E. (2021). Age and sex effects on FGF23-mediated response to mild phosphate challenge. Bone, 146, 115885-1-115885-8.
DOI Scopus15 WoS11 Europe PMC10 |
| 2021 |
Starczak, Y., Reinke, D. C., Barratt, K. R., Russell, P. K., Clarke, M. V., Davey, R. A., . . . Anderson, P. H. (2021). Vitamin D receptor expression in mature osteoclasts reduces bone loss due to low dietary calcium intake in male mice. Journal of Steroid Biochemistry and Molecular Biology, 210, 1-7.
DOI Scopus7 WoS4 Europe PMC2 |
| 2021 |
Grace, T. M., O'Rourke, D., Robertson, T., Perilli, E., Callary, S., Taylor, M., . . . Thewlis, D. (2021). A semi-automated method to quantitatively assess osteolytic lesion volume and bone mineral density within acetabular regions of interest from CT. Journal of Orthopaedic Research, 40(2), 1-13.
DOI Scopus3 WoS3 |
| 2021 |
Bennett, K. J., Millar, S., Fraysse, F., Arnold, J., Atkins, G., Solomon, L., . . . Thewlis, D. (2021). Postoperative lower limb joint kinematics following tibial plateau fracture: a 2-year longitudinal study. Gait and Posture, 83, 20-25.
DOI Scopus7 WoS4 Europe PMC4 |
| 2021 |
Prideaux, M., Wright, C., Noonan, M., Yi, X., Clinkenbeard, E., Mevel, E., . . . Thompson, W. (2021). Generation of Two Multipotent Mesenchymal Progenitor Cell Lines Capable of Osteogenic, Mature Osteocyte, Adipogenic, and Chondrogenic Differentiation.
DOI |
| 2021 |
Muratovic, D., Findlay, D. M., Quarrington, R. D., Cao, X., Solomon, L. B., Atkins, G. J., & Kuliwaba, J. S. (2021). Elevated levels of active Transforming Growth Factor β1 in the subchondral bone relate spatially to cartilage loss and impaired bone quality in human knee osteoarthritis.
DOI |
| 2021 |
Kitchen, D., Richards, J., Smitham, P., Atkins, G., & Solomon, L. (2021). Does Time to Theatre Affect The Ability to Achieve Fracture Reduction in Tibial Plateau Fractures?.
DOI |
| 2021 |
Ormsby, R. T., Zelmer, A. R., Yang, D., Gunn, N. J., Starczak, Y., Kidd, S. P., . . . Atkins, G. J. (2021). Evidence for osteocyte-mediated bone-matrix degradation associated with periprosthetic joint infection (PJI). European Cells and Materials, 41, 264-280.
DOI Scopus14 WoS7 Europe PMC10 |
| 2021 |
Gunn, N. J., Zelmer, A. R., Kidd, S. P., Solomon, L. B., Roscioli, E., Yang, D., & Atkins, G. J. (2021). A Human Osteocyte Cell Line Model for Studying Staphylococcus aureus Persistence in Osteomyelitis. Frontiers in Cellular and Infection Microbiology, 11, 10 pages.
DOI Scopus9 WoS4 Europe PMC7 |
| 2021 |
Prideaux, M., Wright, C. S., Noonan, M. L., Yi, X., Clinkenbeard, E. L., Mevel, E., . . . Thompson, W. R. (2021). Generation of two multipotent mesenchymal progenitor cell lines capable of osteogenic, mature osteocyte, adipogenic, and chondrogenic differentiation. Scientific Reports, 11(1), 22593-1-22593-16.
DOI Scopus10 WoS3 Europe PMC10 |
| 2020 |
Stapledon, C. J. M., Stamenkov, R., Cappai, R., Clark, J. M., Bourke, A., Solomon, L. B., & Atkins, G. J. (2020). Relationships between the Bone Expression of Alzheimer Disease-Related Genes, Bone Remodelling Genes and Cortical Bone Structure in Neck of Femur Fracture. biorxiv.
DOI |
| 2020 |
Ito, N., Prideaux, M., Wijenayaka, A., Yang, D., Ormsby, R., Bonewald, L., & Atkins, G. (2020). Sclerostin directly stimulates osteocyte synthesis of fibroblast growth factor-23.
DOI |
| 2020 |
Callary, S. A., Jones, C. F., Kantar, K., Du Toit, H., Baker, M. P., Thewlis, D., . . . Solomon, L. B. (2020). A new approach to surgical management of tibial plateau fractures. Journal of Clinical Medicine, 9(3), 626-1-626-9.
DOI Scopus8 WoS2 Europe PMC4 |
| 2020 |
Hofstee, M. I., Muthukrishnan, G., Atkins, G. J., Riool, M., Thompson, K., Morgenstern, M., . . . Moriarty, T. F. (2020). Current concepts of osteomyelitis: from pathological mechanisms to advanced research methods.. The American journal of pathology, 190(6), 13 pages.
DOI Scopus74 WoS44 Europe PMC31 |
| 2020 |
Rastin, H., Ormsby, R. T., Atkins, G. J., & Losic, D. (2020). 3D bioprinting of methylcellulose/gelatin-methacryloyl (MC/GelMA) bioink with high shape integrity. ACS Applied Bio Materials, 3(3), 1815-1826.
DOI Scopus100 WoS63 Europe PMC43 |
| 2020 |
Prideaux, M., Wright, C., Noonan, E., Yi, X., Clinkenbeard, E., Mevel, E., . . . Thompson, W. (2020). Generation of two multipotent Mesenchymal Progenitor Cell Lines Capable of Osteogenic, Mature Osteocyte, Adipogenic, and Chondrogenic Differentiation. BioRxiv.
DOI |
| 2019 |
Stapledon, C. J. M., Tsangari, H., Solomon, L. B., Campbell, D. G., Hurtado, P., Krishnan, R., & Atkins, G. J. (2019). Human osteocyte expression of Nerve Growth Factor: the effect of Pentosan Polysulphate Sodium (PPS) and implications for pain associated with knee osteoarthritis. PLoS ONE, 14(9), e0222602-1-e0222602-15.
DOI Scopus17 WoS12 Europe PMC12 |
| 2019 |
Atkins, G., Alberdi, M., Beswick, A., Blaha, J., Bingham, J., Cashman, J., . . . Wyatt, M. (2019). General Assembly, Prevention, Surgical Site Preparation: Proceedings of International Consensus on Orthopedic Infections. Journal of Arthroplasty, 34(2), 85-92.
DOI Scopus12 WoS9 Europe PMC5 |
| 2019 |
Ormsby, R. T., Solomon, L. B., Yang, D., Crotti, T. N., Haynes, D. R., Findlay, D. M., & Atkins, G. J. (2019). Osteocytes respond to particles of clinically-relevant conventional and cross-linked polyethylene and metal alloys by up-regulation of resorptive and inflammatory pathways. Acta Biomaterialia, 87, 296-306.
DOI Scopus41 WoS32 Europe PMC22 |
| 2019 |
Yang, D., Gronthos, S., Isenmann, S., Morris, H. A., & Atkins, G. J. (2019). The late osteoblast/preosteocyte cell line MLO-A5 displays mesenchymal lineage plasticity in vitro and in vivo. Stem Cells International, 2019, 9838167-1-9838167-10.
DOI Scopus4 WoS3 Europe PMC2 |
| 2019 |
Smitham, P. J., Vohora, A., Howie, D. W., Atkins, G. J., & Solomon, L. B. (2019). Surgical Technique to Manage Periprosthetic Fractures of the Knee in Patients with Infected Leg Ulcers. JBJS Case Connector, 9(3), E0347.
DOI |
| 2019 |
Sharma, D. K., Sawyer, R. K., Robertson, T. S., Stamenkov, R., Solomon, L. B., Atkins, G. J., . . . Anderson, P. H. (2019). Elevated Serum 25-Hydroxyvitamin D Levels Are Associated with Improved Bone Formation and Micro-Structural Measures in Elderly Hip Fracture Patients.. Journal of clinical medicine, 8(11), 10 pages.
DOI Scopus13 WoS9 Europe PMC5 |
| 2019 |
Brown, P., Zhou, Y., Tan, A. C., El-Esawi, M. A., Liehr, T., Blanck, O., . . . Tuttle, N. (2019). Large expert-curated database for benchmarking document similarity detection in biomedical literature search. Database, 2019, 1-67.
DOI Scopus21 WoS13 Europe PMC8 |
| 2019 |
Ormsby, R. T., Solomon, L. B., Stamenkov, R., Findlay, D. M., & Atkins, G. J. (2019). Evidence for gender-specific bone loss mechanisms in periprosthetic osteolysis. Journal of Clinical Medicine, 9(1), 1-15.
DOI Scopus6 WoS5 Europe PMC2 |
| 2018 |
Starczak, Y., Reinke, D., Barratt, K., Ryan, J., St-Arnaud, R., Morris, H., . . . Anderson, P. (2018). Absence of vitamin D receptor in mature osteoclasts results in altered osteoclastic activity and bone loss. Journal of Steroid Biochemistry and Molecular Biology, 177, 77-82.
DOI Scopus19 WoS13 Europe PMC6 |
| 2018 |
Yang, D., Wijenayaka, A., Solomon, L., Pederson, S., Findlay, D., Kidd, S., & Atkins, G. (2018). Novel insights into Staphylococcus aureus deep bone infections: the involvement of osteocytes. mBio, 9(2), e00415-18-1-e00415-18-10.
DOI Scopus121 WoS92 Europe PMC74 |
| 2018 |
Solomon, L., Kitchen, D., Anderson, P., Yang, D., Starczak, Y., Kogawa, M., . . . Atkins, G. (2018). Time dependent loss of trabecular bone in human tibial plateau fractures. Journal of Orthopaedic Research, 36(11), 2865-2875.
DOI Scopus3 WoS3 Europe PMC3 |
| 2018 |
Qin, J., Yang, D., Maher, S., Lima-Marques, L., Zhou, Y., Chen, Y., . . . Losic, D. (2018). Micro- and nano-structured 3D printed titanium implants with a hydroxyapatite coating for improved osseointegration. Journal of Materials Chemistry B, 6(19), 3136-3144.
DOI Scopus69 WoS47 Europe PMC12 |
| 2018 |
Yang, D., Wijenayaka, A., & Atkins, G. (2018). A fluorometric method for the quantification of cell number in complex differentiating osteoblast-osteocyte cultures. Methods and Protocols, 1(2), 14.
DOI Scopus1 |
| 2018 |
Yang, D., Anderson, P., Wijenayaka, A., Barratt, K., Triliana, R., Stapledon, C., . . . Atkins, G. (2018). Both ligand and VDR expression levels critically determine the effect of 1α,25-dihydroxyvitamin-D₃ on osteoblast differentiation. Journal of Steroid Biochemistry and Molecular Biology, 177, 83-90.
DOI Scopus14 WoS10 Europe PMC8 |
| 2018 |
Kogawa, M., Khalid, K., Wijenayaka, A., Ormsby, R., Evdokiou, A., Anderson, P., . . . Atkins, G. (2018). Recombinant sclerostin antagonises effects of ex vivo mechanical loading in trabecular bone and increases osteocyte lacunar size. American Journal of Physiology - Cell Physiology, 314(1), 53-61.
DOI Scopus25 WoS20 Europe PMC15 |
| 2017 |
Panagopoulos, V., Liapis, V., Zinonos, I., Hay, S., Leach, D. A., Ingman, W., . . . Evdokiou, A. (2017). Peroxidase enzymes inhibit osteoclast differentiation and bone resorption. Molecular and Cellular Endocrinology, 440(C), 8-15.
DOI Scopus17 WoS15 Europe PMC13 |
| 2017 |
Zysk, A., DeNichilo, M., Panagopoulos, V., Zinonos, I., Liapis, V., Hay, S., . . . Evdokiou, A. (2017). Adoptive transfer of ex vivo expanded Vγ9Vδ2 T cells in combination with zoledronic acid inhibits cancer growth and limits osteolysis in a murine model of osteolytic breast cancer. Cancer Letters, 386, 141-150.
DOI Scopus20 WoS17 Europe PMC13 |
| 2017 |
Gulati, K., Prideaux, M., Kogawa, M., Lima-Marques, L., Atkins, G. J., Findlay, D. M., & Losic, D. (2017). Anodized 3D-printed titanium implants with dual micro- and nano-scale topography promote interaction with human osteoblasts and osteocyte-like cells. Journal of Tissue Engineering and Regenerative Medicine, 11(12), 3313-3325.
DOI Scopus86 WoS70 Europe PMC23 |
| 2017 |
Thewlis, D., Fraysse, F., Callary, S., Verghese, V., Jones, C., Findlay, D., . . . Solomon, L. (2017). Postoperative weight bearing and patient reported outcomes at one year following tibial plateau fractures. Injury, 48(7), 1650-1656.
DOI Scopus28 WoS17 Europe PMC14 |
| 2017 |
Reinke, D., Starczak, Y., Kogawa, M., Barratt, K., Morris, H., Anderson, P., & Atkins, G. (2017). Evidence for altered osteoclastogenesis in splenocyte cultures from VDR knockout mice. Journal of Steroid Biochemistry and Molecular Biology, 177, 96-102.
DOI Scopus2 WoS1 |
| 2017 |
Liapis, V., Zysk, A., DeNichilo, M., Zinonos, I., Hay, S., Panagopoulos, V., . . . Evdokiou, A. (2017). Anticancer efficacy of the hypoxia-activated prodrug evofosfamide is enhanced in combination with proapoptotic receptor agonists against osteosarcoma. Cancer Medicine, 6(9), 2164-2176.
DOI Scopus8 WoS7 Europe PMC5 |
| 2016 |
Saad, S., Dharmapatni, A., Crotti, T., Cantley, M., Algate, K., Findlay, D., . . . Haynes, D. (2016). Semaphorin-3a, neuropilin-1 and plexin-A1 in prosthetic-particle induced bone loss. Acta Biomaterialia, 30, 311-318.
DOI Scopus20 WoS14 Europe PMC12 |
| 2016 |
DeNichilo, M., Shoubridge, A., Panagopoulos, V., Liapis, V., Zysk, A., Zinonos, I., . . . Evdokiou, A. (2016). Peroxidase enzymes regulate collagen biosynthesis and matrix mineralization by cultured human osteoblasts. Calcified Tissue International, 98(3), 294-305.
DOI Scopus12 WoS11 Europe PMC9 |
| 2016 |
Reinke, D., Kogawa, M., Barratt, K., Morris, H., Anderson, P., & Atkins, G. (2016). Evidence for altered osteoclastogenesis in splenocyte cultures from Cyp27b1 knockout mice. Journal of Steroid Biochemistry and Molecular Biology, 164, 353-360.
DOI Scopus9 WoS4 Europe PMC5 |
| 2016 |
Wijenayaka, A., Prideaux, M., Yang, D., Morris, H., Findlay, D., Anderson, P., & Atkins, G. (2016). Early response of the human SOST gene to stimulation by 1α,25-dihydroxyvitamin D₃. Journal of Steroid Biochemistry and Molecular Biology, 164, 369-373.
DOI Scopus13 WoS9 Europe PMC10 |
| 2016 |
Ryan, J., Starczak, Y., Tsangari, H., Sawyer, R., Davey, R., Atkins, G., . . . Anderson, P. (2016). Sex-related differences in the skeletal phenotype of aged vitamin D receptor global knockout mice. Journal of Steroid Biochemistry and Molecular Biology, 164, 361-368.
DOI Scopus14 WoS12 Europe PMC8 |
| 2016 |
Liapis, V., Zinonos, I., Labrinidis, A., Hay, S., Ponomarev, V., Panagopoulos, V., . . . Evdokiou, A. (2016). Anticancer efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in osteolytic breast cancer murine models. Cancer Medicine, 5(3), 534-545.
DOI Scopus25 WoS21 Europe PMC20 |
| 2016 |
Ormsby, R., Cantley, M., Kogawa, M., Solomon, L., Haynes, D., Findlay, D., & Atkins, G. (2016). Evidence that osteocyte perilacunar remodelling contributes to polyethylene wear particle induced osteolysis. Acta Biomaterialia, 33, 242-251.
DOI Scopus60 WoS46 Europe PMC29 |
| 2016 |
Prideaux, M., Findlay, D., & Atkins, G. (2016). Osteocytes: the master cells in bone remodelling. Current Opinion in Pharmacology, 28, 24-30.
DOI Scopus156 WoS128 Europe PMC93 |
| 2016 |
Yang, D., Anderson, P., Turner, A., Morris, H., & Atkins, G. (2016). Comparison of the biological effects of exogenous and endogenous 1,25-dihydroxyvitamin D₃ on the mature osteoblast cell line MLO-A5. Journal of Steroid Biochemistry and Molecular Biology, 164, 374-378.
DOI Scopus5 WoS4 Europe PMC4 |
| 2016 |
Prideaux, M., Schutz, C., Wijenayaka, A. R., Findlay, D. M., Campbell, D. G., Solomon, L. B., & Atkins, G. J. (2016). Isolation of osteocytes from human trabecular bone. Bone, 88, 64-72.
DOI Scopus34 WoS28 Europe PMC17 |
| 2016 |
Gulati, K., Kogawa, M., Prideaux, M., Findlay, D., Atkins, G., & Losic, D. (2016). Drug-releasing nano-engineered titanium implants: therapeutic efficacy in 3D cell culture model, controlled release and stability. Materials Science and Engineering C, 69, 831-840.
DOI Scopus58 WoS46 Europe PMC10 |
| 2016 |
Derrick-Roberts, A., Panir, K., Pyragius, C., Zarrinkalam, K., Atkins, G., & Byers, S. (2016). Reversal of established bone pathology in MPS VII mice following lentiviral-mediated gene therapy. Molecular Genetics and Metabolism, 119(3), 249-257.
DOI Scopus12 WoS12 Europe PMC9 |
| 2016 |
Rahman, S., Gulati, K., Kogawa, M., Atkins, G., Pivonka, P., Findlay, D., & Losic, D. (2016). Drug diffusion, integration, and stability of nanoengineered drug-releasing implants in bone ex-vivo. Journal of Biomedical Materials Research Part A, 104(3), 714-725.
DOI Scopus32 WoS30 Europe PMC10 |
| 2016 |
Triliana, R., Lam, N., Sawyer, R., Atkins, G., Morris, H., & Anderson, P. (2016). Skeletal characterization of an osteoblast-specific vitamin D receptor transgenic (ObVDR-B6) mouse model. Journal of Steroid Biochemistry and Molecular Biology, 164, 331-336.
DOI Scopus10 WoS7 Europe PMC7 |
| 2015 |
Rahman, S., Ormsby, R., Santos, A., Atkins, G., Findlay, D., & Losic, D. (2015). Nanoengineered drug-releasing aluminium wire implants: comparative investigation of nanopore geometry, drug release and osteoblast cell adhesion. RSC Advances, 5(92), 75004-75014.
DOI Scopus6 WoS6 |
| 2015 |
Ito, N., Wijenayaka, A., Prideaux, M., Kogawa, M., Ormsby, R., Evdokiou, A., . . . Atkins, G. (2015). Regulation of FGF23 expression in IDG-SW3 osteocytes and human bone by pro-inflammatory stimuli. Molecular and Cellular Endocrinology, 399(C), 208-218.
DOI Scopus141 WoS126 Europe PMC102 |
| 2015 |
Liapis, V., Labrinidis, A., Zinonos, I., Hay, S., Ponomarev, V., Panagopoulos, V., . . . Evdokiou, A. (2015). Hypoxia-activated pro-drug TH-302 exhibits potent tumor suppressive activity and cooperates with chemotherapy against osteosarcoma. Cancer Letters, 357(1), 160-169.
DOI Scopus40 WoS36 Europe PMC32 |
| 2015 |
Van De Pol, G., Iselin, L., Callary, S., Thewlis, D., Jones, C., Atkins, G., & Solomon, L. (2015). Impaction bone grafting has potential as an adjunct to the surgical stabilisation of osteoporotic tibial plateau fractures: early results of a case series. Injury, 46(6), 1089-1096.
DOI Scopus17 WoS13 Europe PMC11 |
| 2015 |
Rahman, S., Atkins, G., Findlay, D., & Losic, D. (2015). Nanoengineered drug releasing aluminium wire implants: a model study for localized bone therapy. Journal of Materials Chemistry B, 3(16), 3288-3296.
DOI Scopus14 WoS12 Europe PMC3 |
| 2015 |
Yang, D., Turner, A., Wijenayaka, A., Anderson, P., Morris, H., & Atkins, G. (2015). 1,25-Dihydroxyvitamin D₃ and extracellular calcium promote mineral deposition via NPP1 activity in a mature osteoblast cell line MLO-A5. Molecular and Cellular Endocrinology, 412(C), 140-147.
DOI Scopus22 WoS17 Europe PMC12 |
| 2015 |
Wijenayaka, A., Yang, D., Prideaux, M., Ito, N., Kogawa, M., Anderson, P., . . . Atkins, G. (2015). 1α,25-dihydroxyvitamin D3 stimulates human SOST gene expression and sclerostin secretion. Molecular and Cellular Endocrinology, 413(C), 157-167.
DOI Scopus41 WoS32 Europe PMC27 |
| 2015 |
Clarke, M., Russell, P., Findlay, D., Sastra, S., Anderson, P., Skinner, J., . . . Davey, R. (2015). A role for the Calcitonin respetor to limit bone loss during lactation in female mice by inhibiting osteocytic osteolysis. Endocrinology, 156(9), 3203-3214.
DOI Scopus47 WoS33 Europe PMC22 |
| 2015 |
Saji, V., Kumeria, T., Gulati, K., Prideaux, M., Rahman, S., Alsawat, M., . . . Losic, D. (2015). Localized drug delivery of selenium (Se) using nanoporous anodic aluminium oxide for bone implants. Journal of Materials Chemistry B, 3(35), 7090-7098.
DOI Scopus23 WoS22 Europe PMC4 |
| 2015 |
Yang, D., Atkins, G. J., Turner, A. G., Anderson, P. H., & Morris, H. A. (2015). Erratum: Differential effects of 1,25-dihydroxyvitamin D on mineralisation and differentiation in two different types of osteoblast-like cultures (Journal of Steroid Biochemistry and Molecular Biology (2013) 136 166-170). Journal of Steroid Biochemistry and Molecular Biology, 147, 125.
DOI |
| 2014 |
Lam, N., Triliana, R., Sawyer, R., Atkins, G., Morris, H., O'Loughlin, P., & Anderson, P. (2014). Vitamin D receptor overexpression in osteoblasts and osteocytes prevents bone loss during vitamin D-deficiency. Journal of Steroid Biochemistry and Molecular Biology, 144(PART A), 128-131.
DOI Scopus33 WoS25 Europe PMC16 |
| 2014 |
Prideaux, M., Wijenayaka, A., Kumarasinghe, D., Ormsby, R., Evdokiou, A., Findlay, D., & Atkins, G. (2014). SaOS2 osteosarcoma cells as an in vitro model for studying the transition of human osteoblasts to osteocytes. Calcified Tissue International, 95(2), 183-193.
DOI Scopus93 WoS79 Europe PMC56 |
| 2014 |
Zinonos, I., Luo, K., Labrinidis, A., Liapis, V., Hay, S., Panagopoulos, V., . . . Evdokiou, A. (2014). Pharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancer. International Journal of Oncology, 45(2), 532-540.
DOI Scopus20 WoS20 Europe PMC16 |
| 2014 |
Findlay, D. M., & Atkins, G. J. (2014). Osteoblast-chondrocyte interactions in osteoarthritis. Current Osteoporosis Reports, 12(1), 127-134.
DOI Scopus112 WoS96 Europe PMC77 |
| 2014 |
Ito, N., Findlay, D., & Atkins, G. (2014). Osteocyte communication with the kidney via the production of FGF23: Remote control of phosphate homeostasis. Clinical Reviews in Bone and Mineral Metabolism, 12(1), 44-58.
DOI Scopus9 WoS7 |
| 2014 |
Ito, N., Peña, A., Perano, S., Atkins, G., Findlay, D., & Couper, J. (2014). First Australian report of vitamin D-dependent rickets type I. Medical Journal of Australia, 201(7), 420-421.
DOI Scopus4 WoS3 Europe PMC2 |
| 2014 |
Zinonos, I., Labrinidis, A., Liapis, V., Hay, S., Panagopoulos, V., Denichilo, M., . . . Evdokiou, A. (2014). Doxorubicin overcomes resistance to drozitumab by antagonizing inhibitor of apoptosis proteins (IAPS). Anticancer Research, 34(12), 7007-7020.
Scopus6 WoS4 Europe PMC5 |
| 2013 |
Yang, D., Atkins, G., Turner, A., Anderson, P., & Morris, H. (2013). Differential effects of 1,25-dihydroxyvitamin D on mineralisation and differentiation in two different types of osteoblast-like cultures. Journal of Steroid Biochemistry and Molecular Biology, 136(1), 166-170.
DOI Scopus27 WoS23 Europe PMC17 |
| 2013 |
Kogawa, M., Findlay, D., Anderson, P., & Atkins, G. (2013). Modulation of osteoclastic migration by metabolism of 25(OH)-vitamin D₃. Journal of Steroid Biochemistry and Molecular Biology, 136(1), 59-61.
DOI Scopus15 WoS12 Europe PMC8 |
| 2013 |
Anderson, P., Lam, N., Turner, A., Davey, R., Kogawa, M., Atkins, G., & Morris, H. (2013). The pleiotropic effects of vitamin D in bone. Journal of Steroid Biochemistry and Molecular Biology, 136(1), 190-194.
DOI Scopus56 WoS46 Europe PMC31 |
| 2013 |
Kato, N., Matsumoto, M., Kogawa, M., Atkins, G., Findlay, D., Fujikawa, T., . . . Ogata, M. (2013). Critical role of p38 MAPK for regeneration of the sciatic nerve following crush injury in vivo. Journal of Neuroinflammation, 10(1), 1-13.
DOI Scopus48 WoS42 Europe PMC49 |
| 2013 |
Ryan, J., Reinke, D., Kogawa, M., Turner, A., Atkins, G., Anderson, P., & Morris, H. (2013). Novel targets of vitamin D activity in bone: action of the vitamin D receptor in osteoblasts, osteocytes and osteoclasts. Current Drug Targets, 14(14), 1683-1688.
DOI Scopus21 WoS20 Europe PMC17 |
| 2013 |
Kogawa, M., Wijenayaka, A., Ormsby, R., Thomas, G., Anderson, P., Bonewald, L., . . . Atkins, G. (2013). Sclerostin regulates release of bone mineral by osteocytes by induction of carbonic anhydrase 2. Journal of Bone and Mineral Research, 28(12), 2436-2448.
DOI Scopus133 WoS113 Europe PMC81 |
| 2013 |
Howie, D., Neale, S., Haynes, D., Holubowycz, O., McGee, M., Solomon, L., . . . Findlay, D. (2013). Periprosthetic osteolysis after total hip replacement: molecular pathology and clinical management. Inflammopharmacology, 21(6), 389-396.
DOI Scopus39 WoS30 Europe PMC23 |
| 2013 |
Kogawa, M., Hisatake, K., Atkins, G., Findlay, D., Enoki, Y., Sato, T., . . . Matsumoto, M. (2013). The paired-box homeodomain transcription factor Pax6 binds to the upstream region of the TRAP gene promoter and suppresses receptor activator of NF-kB ligand (RANKL)-induced Osteoclast differentiation. Journal of Biological Chemistry, 288(43), 31299-31312.
DOI Scopus20 WoS20 Europe PMC15 |
| 2013 |
Welldon, K., Findlay, D., Evdokiou, A., Ormsby, R., & Atkins, G. (2013). Calcium induces pro-anabolic effects on human primary osteoblasts associated with acquisition of mature osteocyte markers. Molecular and Cellular Endocrinology, 376(1), 85-92.
DOI Scopus25 WoS24 Europe PMC19 |
| 2013 |
Ito, N., Findlay, D., Anderson, P., Bonewald, L., & Atkins, G. (2013). Extracellular phosphate modulates the effect of 1α,25-dihydroxy vitamin D₃ (1,25D) on osteocyte like cells. Journal of Steroid Biochemistry and Molecular Biology, 136(1), 183-186.
DOI Scopus50 WoS42 Europe PMC38 |
| 2012 |
Kumarasinghe, D., Sullivan, T., Kuliwaba, J., Fazzalari, N., & Atkins, G. (2012). Evidence for the dysregulated expression of TWIST1, TGFβ1 and SMAD3 in differentiating osteoblasts from primary hip osteoarthritis patients. Osteoarthritis and Cartilage, 20(11), 1357-1366.
DOI Scopus29 WoS25 Europe PMC18 |
| 2012 |
Aw, M., Khalid, K., Gulati, K., Atkins, G., Pivonka, P., Findlay, D., & Losic, D. (2012). Characterization of drug-release kinetics in trabecular bone from titania nanotube implants. International Journal of Nanomedicine (online), 7, 4883-4892.
DOI Scopus53 WoS44 Europe PMC15 |
| 2012 |
Atkins, G., & Findlay, D. (2012). Osteocyte regulation of bone mineral: a little give and take. Osteoporosis International, 23(8), 2067-2079.
DOI Scopus132 WoS108 Europe PMC81 |
| 2012 |
Alias, E., Dharmapatni, A., Holding, C., Atkins, G., Findlay, D., Howie, D., . . . Haynes, D. (2012). Polyethylene particles stimulate expression of ITAM-related molecules in peri-implant tissues and when stimulating osteoclastogenesis in vitro. Acta Biomaterialia, 8(8), 3104-3112.
DOI Scopus20 WoS19 Europe PMC16 |
| 2012 |
Zarrinkalam, M., Mulaibrahimovic, A., Atkins, G., & Moore, R. (2012). Changes in osteocyte density correspond with changes in osteoblast and osteoclast activity in an osteoporotic sheep model. Osteoporosis International, 23(0004), 1329-1336.
DOI Scopus46 WoS40 Europe PMC24 |
| 2012 |
Gulati, K., Ramakrishnan, S., Aw, M., Atkins, G., Findlay, D., & Losic, D. (2012). Biocompatible polymer coating of titania nanotube arrays for improved drug elution and osteoblast adhesion. Acta Biomaterialia, 8(1), 449-456.
DOI Scopus271 WoS230 Europe PMC79 |
| 2012 |
Bhattacharjee, M., Raju, R., Radhakrishnan, A., Nanjappa, V., Muthusamy, B., Singh, K., . . . Chatterjee, A. (2012). A bioinformatics resource for TWEAK-Fn14 signaling pathway. Journal of Signal Transduction, 2012, 376470-1-376470-10.
DOI |
| 2011 |
Kumarasinghe, D., Hopwood, B., Kuliwaba, J., Atkins, G., & Fazzalari, N. (2011). An update on primary hip osteoarthritis including altered Wnt and TGF-beta associated gene expression from the bony component of the disease. Rheumatology, 50(12), 2166-2175.
DOI Scopus15 WoS14 Europe PMC13 |
| 2011 |
Anderson, P., Atkins, G., Turner, A., Kogawa, M., Findlay, D., & Morris, H. (2011). Vitamin D metabolism within bone cells: Effects on bone structure and strength. Molecular and Cellular Endocrinology, 347(1-2 Sp Is), 42-47.
DOI Scopus52 WoS49 Europe PMC26 |
| 2011 |
Wijenayaka, A., Kogawa, M., Lim, H., Bonewald, L., Findlay, D., & Atkins, G. (2011). Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway. PLoS One, 6(10), e25900-1-e25900-9.
DOI Scopus406 WoS346 Europe PMC261 |
| 2011 |
Findlay, D., & Atkins, G. (2011). Relationship between serum RANKL and RANKL in bone. Osteoporosis International, 22(10), 2597-2602.
DOI Scopus62 WoS52 Europe PMC42 |
| 2011 |
Dharmapatni, A., Smith, M., Crotti, T., Holding, C., Vincent, C., Weedon, H., . . . Haynes, D. (2011). TWEAK and Fn14 expression in the pathogenesis of joint inflammation and bone erosion in rheumatoid arthritis. Arthritis Research & Therapy, 13(2), R51-1-R51-10.
DOI Scopus35 WoS31 Europe PMC25 |
| 2011 |
Atkins, G., Rowe, P., Lim, H., Welldon, K., Ormsby, R., Wijenayaka, A., . . . Findlay, D. (2011). Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism. Journal of Bone and Mineral Research, 26(7), 1425-1436.
DOI Scopus209 WoS185 Europe PMC148 |
| 2011 |
Atkins, G., Haynes, D., Howie, D., & Findlay, D. (2011). Role of polyethylene particles in peri-prosthetic osteolysis: A review. World Journal of Orthopedics, 2(10), 93-101.
DOI Scopus47 WoS32 Europe PMC25 |
| 2010 |
Kumarasinghe, D., Perilli, E., Tsangari, H., Truong, L., Kuliwaba, J., Hopwood, B., . . . Fazzalari, N. (2010). Critical molecular regulators, histomorphometric indices and their correlations in the trabecular bone in primary hip osteoarthritis. Osteoarthritis and Cartilage, 18(10), 1337-1344.
DOI Scopus24 WoS23 Europe PMC17 |
| 2010 |
Kogawa, M., Findlay, D., Anderson, P., Ormsby, R., Vincent, C., Morris, H., & Atkins, G. (2010). Osteoclastic metabolism of 25(OH)-vitamin D-3: A potential mechanism for optimization of bone resorption. Endocrinology, 151(10), 4613-4625.
DOI Scopus124 WoS101 Europe PMC71 |
| 2010 |
Kataria, N., Bartold, P., Dharmapatni, A., Atkins, G., Holding, C., & Haynes, D. (2010). Expression of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor, fibroblast growth factor-inducible 14 protein (Fn14), in healthy tissues and in tissues affected by periodontitis. Journal of Periodontal Research, 45(4), 564-573.
DOI Scopus18 WoS18 Europe PMC10 |
| 2010 |
Williams, S., Martin, S., Vincent, C., Gronthos, S., Zheng, T., Atkins, G., & Zannettino, A. (2010). Circulating levels of TWEAK correlate with bone erosion in multiple myeloma patients. British Journal of Haematology, 150(3), 373-376.
DOI Scopus6 WoS6 Europe PMC3 |
| 2010 |
Kogawa, M., Anderson, P., Findlay, D., Morris, H., & Atkins, G. (2010). The metabolism of 25-(OH)vitamin D3 by osteoclasts and their precursors regulates the differentiation of osteoclasts. Journal of Steroid Biochemistry and Molecular Biology, 121(1-2 Sp Iss), 277-280.
DOI Scopus65 WoS52 Europe PMC29 |
| 2009 |
Atkins, G., Welldon, K., Wijenayaka, A., Bonewald, L., & Findlay, D. (2009). Vitamin K promotes mineralization, osteoblast-to-osteocyte transition, and an anticatabolic phenotype by y-carboxylation-dependent and -independent mechanisms. American Journal of Physiology-Cell Physiology, 297(6), C1358-C1367.
DOI Scopus104 WoS98 Europe PMC73 |
| 2009 |
Vincent, C., Findlay, D., Welldon, K., Wijenayaka, A., Zheng, T., Haynes, D., . . . Atkins, G. (2009). Pro-inflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNF alpha induce the mitogen-activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts. Journal of Bone and Mineral Research, 24(8), 1434-1449.
DOI Scopus152 WoS145 Europe PMC103 |
| 2009 |
Wijenayaka, A., Colby, C., Atkins, G., & Majewski, P. (2009). Biomimetic hydroxyapatite coating on glass coverslips for the assay of osteoclast activity in vitro. Journal of Materials Science-Materials in Medicine, 20(7), 1467-1473.
DOI Scopus13 WoS13 Europe PMC6 |
| 2009 |
Atkins, G., Welldon, K., Holding, C., Haynes, D., Howie, D., & Findlay, D. (2009). The induction of a catabolic phenotype in human primary osteoblasts and osteocytes by polyethylene particles. Biomaterials, 30(22), 3672-3681.
DOI Scopus85 WoS80 Europe PMC68 |
| 2009 |
Labrinidis, A., Diamond, P., Martin, S., Hay, S., Liapis, V., Zinonos, I., . . . Evdokiou, A. (2009). Apo2L/TRAIL inhibits tumor growth and bone destruction in a murine model of multiple myeloma. Clinical Cancer Research, 15(6), 1998-2009.
DOI Scopus33 WoS30 Europe PMC27 |
| 2009 |
Vincent, C., Kogawa, M., Findlay, D., & Atkins, G. (2009). The generation of osteoclasts from RAW 264.7 precursors in defined, serum-free conditions. Journal of Bone and Mineral Metabolism, 27(1), 114-119.
DOI Scopus56 WoS49 Europe PMC37 |
| 2009 |
Atkins, G., Welldon, K., Halbout, P., & Findlay, D. (2009). Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response. Osteoporosis International, 20(4), 653-664.
DOI Scopus173 WoS151 Europe PMC108 |
| 2008 |
Moffatt, P., Gaumond, M., Salois, P., Sellin, K., Bessette, M., Godin, E., . . . Thomas, G. (2008). Bril: A novel bone-specific modulator of mineralization. Journal of Bone and Mineral Research, 23(9), 1497-1508.
DOI Scopus128 WoS117 Europe PMC108 |
| 2008 |
Davey, R., Turner, A., McManus, J., Chiu, W., Tjahyono, F., Moore, A., . . . Zajac, J. (2008). Calcitonin receptor plays a physiological role to protect against hypercalcemia in mice. Journal of Bone and Mineral Research, 23(8), 1182-1193.
DOI Scopus89 WoS73 Europe PMC41 |
| 2008 |
Welldon, K., Atkins, G., Howie, D., & Finlay, D. (2008). Primary human osteoblasts grow into porous tantalum and maintain an osteoblastic phenotype. Journal of Biomedical Materials Research. Part A, 84A(3), 691-701.
DOI Scopus85 WoS74 Europe PMC36 |
| 2008 |
Anderson, P., & Atkins, G. (2008). The skeleton as an intracrine organ for vitamin D metabolism. Molecular Aspects of Medicine, 29(6), 397-406.
DOI Scopus81 WoS76 Europe PMC50 |
| 2008 |
Labrinidis, A., Liapis, V., Thai, L., Atkins, G., Vincent, C., Hay, S., . . . Evdokiou, A. (2008). Does Apo2LTRAIL play any physiologic role in osteoclastogenesis?. Blood, 111(11), 5411-5412.
DOI Scopus19 WoS15 Europe PMC8 |
| 2007 |
Atkins, G., Anderson, P., Findlay, D., Welldon, K., Vincent, C., Zannettino, A., . . . Morris, H. (2007). Metabolism of vitamin D₃ in human osteoblasts: Evidence for autocrine and paracrine activities of 1α,25-dihydroxyvitamin D₃. Bone, 40(6), 1517-1528.
DOI Scopus217 WoS188 Europe PMC142 |
| 2007 |
Anderson, P., Atkins, G., Findlay, D., O'Loughlin, P., Welldon, K., Vincent, C., & Morris, H. (2007). RNAi-mediated silencing of CYP27B1 abolishes 1,25(OH)₂D₃ synthesis and reduces osteocalcin and CYP24 mRNA expression in human osteosarcoma (HOS) cells. Journal of Steroid Biochemistry and Molecular Biology, 103(3-5 Sp Iss), 601-605.
DOI Scopus43 WoS34 Europe PMC19 |
| 2007 |
Atkins, G. J., Welldon, K. J., & Findlay, D. M. (2007). Strontium ranelate promotes an osteocyte-like phenotype from human primary osteoblasts ex vivo. CALCIFIED TISSUE INTERNATIONAL, 80, S71-S72. |
| 2006 |
Holding, C., Findlay, D., Stamenkov, R., Neale, S., Lucas, H., Dharmapatni, A., . . . Haynes, D. (2006). The correlation of RANK, RANKL and TNFα expression with bone loss volume and polyethylene wear debris around hip implants. Biomaterials, 27(30), 5212-5219.
DOI Scopus111 WoS98 Europe PMC73 |
| 2006 |
Atkins, G., Kostakis, P., Vincent, C., Farrugia, A., Houchins, J., Findlay, D., . . . Zannettino, A. (2006). RANK expression as a cell surface marker of human osteoclast precursors in peripheral blood, bone marrow, and giant cell tumors of bone. Journal of Bone and Mineral Research, 21(9), 1339-1349.
DOI Scopus111 WoS103 Europe PMC81 |
| 2006 |
Perper, S., Browning, B., Burkly, L., Weng, S., Gao, C., Giza, K., . . . Hess, H. (2006). TWEAK is a novel arthritogenic mediator. Journal of Immunology, 177(4), 2610-2620.
DOI Scopus144 WoS134 Europe PMC97 |
| 2005 |
Zannettino, A., Holding, C., Diamond, P., Atkins, G., Kostakis, P., Farrugia, A., . . . Haynes, D. (2005). Osteoprotegerin (OPG) is localized to the Weibel-Palade bodies of human vascular endothelial cells and is physically associated with von Willebrand factor. Journal of Cellular Physiology, 204(2), 714-723.
DOI Scopus143 WoS141 Europe PMC97 |
| 2005 |
Morgan, T., Atkins, G., Trivett, M., Johnson, S., Kansara, M., Schlicht, S., . . . Thomas, D. (2005). Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kB. American Journal of Pathology, 167(1), 117-128.
DOI Scopus117 WoS103 Europe PMC87 |
| 2005 |
Atkins, G., Kostakis, P., Welldon, K., Vincent, C., Findlay, D., & Zannettino, A. (2005). Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium. Journal of Cellular Physiology, 203(3), 573-582.
DOI Scopus30 WoS29 Europe PMC24 |
| 2004 |
Zannettino, A., Pan, B., Farrugia, A., Atkins, G., & To, L. (2004). Identification and clinical relevance of receptor activator of nuclear factor kappa B ligand expression of myeloma cells - Reply. Cancer Research, 64(2), 774-775. |
| 2004 |
Tsangari, H., Findlay, D., Kuliwaba, J., Atkins, G., & Fazzalari, N. (2004). Increased expression of IL-6 and RANK mRNA in human trabecular bone from fragility fracture of the femoral neck. Bone, 35(1), 334-342.
DOI Scopus57 WoS54 Europe PMC39 |
| 2004 |
Bouralexis, S., Clayer, M., Atkins, G., Labrinidis, A., Hay, S., Graves, S., . . . Evdokiou, A. (2004). Sensitivity of fresh isolates of soft tissue sarcoma, osteosarcoma and giant cell tumour cells to Apo2L/TRAIL and doxorubicin. International Journal of Oncology, 24(5), 1263-1270.
DOI Scopus14 WoS14 Europe PMC8 |
| 2004 |
Findlay, D., Welldon, K., Atkins, G., Howie, D., Zannettino, A., & Bobyn, D. (2004). The proliferation and phenotypic expression of human osteoblasts on tantalum metal. Biomaterials, 25(12), 2215-2227.
DOI Scopus188 WoS161 Europe PMC72 |
| 2004 |
Pan, B., To, L., Farrugia, A., Findlay, D., Green, J., Gronthos, S., . . . Zannettino, A. (2004). The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitro. Bone, 34(1), 112-123.
DOI Scopus101 WoS91 Europe PMC67 |
| 2004 |
Hu, Y., Zhou, H., Myers, D., Quinn, J., Atkins, G., Ly, C., . . . Ng, K. (2004). Isolation of a human homolog of osteoclast inhibitory lectin that inhibits the formation and function of osteoclasts. Journal of Bone and Mineral Research, 19(1), 89-99.
DOI Scopus44 WoS39 Europe PMC32 |
| 2004 |
Heider, U., Zavrski, I., Jakob, C., Fleissner, C., Sezer, O., Zannettino, A. C. W., . . . Bik To, L. (2004). Identification and Clinical Relevance of Receptor Activator of Nuclear Factor κB Ligand Expression of Myeloma Cells [2] (multiple letters). Cancer Research, 64(2), 773-775.
Scopus1 |
| 2003 |
Haynes, D., Barg, E., Crotti, T., Holding, C., Weedon, H., Atkins, G., . . . Smith, M. (2003). Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controls. Rheumatology, 42(1), 123-134.
DOI Scopus136 WoS122 Europe PMC92 |
| 2003 |
Atkins, G., Kostakis, P., Pan, B., Farrugia, A., Gronthos, S., Evdokiou, A., . . . Zannettino, A. (2003). RANKL expression is related to the differentiation state of human osteoblasts. Journal of Bone and Mineral Research, 18(6), 1088-1098.
DOI Scopus213 WoS194 Europe PMC146 |
| 2003 |
Farrugia, A., Atkins, G., To, L., Pan, B., Horvath, N., Kostakis, P., . . . Zannettino, A. (2003). Receptor activator of nuclear factor-kB ligand expression by human myeloma cells mediates osteoclast formation in vitro and correlates with bone destruction in vivo. Cancer Research, 63(17), 5438-5445.
Scopus201 WoS185 Europe PMC138 |
| 2003 |
Bouralexis, S., Findlay, D., Atkins, G., Labrinidis, A., Hay, S., & Evdokiou, A. (2003). Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapy. British Journal of Cancer, 89(1), 206-214.
DOI Scopus62 WoS59 Europe PMC36 |
| 2003 |
Pan, B., To, L., Farrugia, A., Kostakis, P., Atkins, G., Findlay, D., & Zannettino, A. (2003). Multiple myeloma-derived pro-inflammatory cytokines enhance osteoclastogenesis by increasing the number of RANKL-expressing STRO-1 positive osteoprogenitor cells. Blood, 102(11), 5207. |
| 2002 |
Atkins, G., Bouralexis, S., Evdokiou, A., Hay, S., Labrinidis, A., Zannettino, A., . . . Findlay, D. (2002). Human osteoblasts are resistant to Apo2L/TRAIL-mediated apoptosis. Bone, 31(4), 448-456.
DOI Scopus60 WoS60 Europe PMC38 |
| 2002 |
Findlay, D., Raggatt, L., Bouralexis, S., Hay, S., Atkins, G., & Evdokiou, A. (2002). Calcitonin decreases the adherence and survival of HEK-293 cells by a caspase-independent mechanism. Journal of Endocrinology, 175(3), 715-725.
DOI Scopus20 WoS14 Europe PMC10 |
| 2002 |
Evdokiou, A., Bouralexis, S., Atkins, G., Chai, F., Hay, S., Clayer, M., & Findlay, D. (2002). Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to APO2L/TRIAL-induced apoptosis. International Journal of Cancer, 99(4), 491-504.
DOI Scopus132 WoS131 Europe PMC84 |
| 2002 |
Atkins, G., Haynes, D., Zannettino, A., Capone, M., Crotti, T., & Findlay, D. (2002). Haemopoietic cells influence stromal cell gene expression during human osteoclast development. Journal of Bone and Joint Surgery - British Volume, 84B(Suppl.3), 235. |
| 2002 |
Atkins, G., Crotti, T., Loric, M., Findlay, D., Howie, D., Bain, G., & Haynes, D. (2002). Periprosthetic osteolysis is associated with wear particles stimulating factors that control osteoclast formation. Journal of Bone and Joint Surgery - British Volume, 84B(Suppl.3), 234. |
| 2002 |
Atkins, G., Crotti, T., Loric, M., Findlay, D., Smith, M., & Haynes, D. (2002). Osteolysis in bone loss pathologies is associated with similar factors that control osteoclast formation. Asia Pacific Orthopaedic Association.. Journal of Bone and Joint Surgery - British Volume, 84B(Suppl.3), 234-235. |
| 2001 |
Kuliwaba, J. S., Findlay, D. M., Atkins, G. J., Forwood, M. R., & Fazzalari, N. L. (2001). Gene expression in human cancellous bone is similar between skeletal sites.. JOURNAL OF BONE AND MINERAL RESEARCH, 16, S327. |
| 2001 |
Zarrinkalam, K., Leavesley, D., Stanley, J., Atkins, G., & Faull, R. (2001). Expression of defensin antimicrobial peptides in the peritoneal cavity of patients on peritoneal dialysis. Peritoneal Dialysis International, 21(5), 501-508.
DOI Scopus15 WoS13 Europe PMC6 |
| 2001 |
Haynes, D., Crotti, T., Loric, M., Bain, G., Atkins, G., & Findlay, D. (2001). Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint. Rheumatology, 40(6), 623-630.
DOI Scopus188 WoS165 Europe PMC121 |
| 2001 |
Haynes, D., Crotti, T., Potter, A., Loric, M., Atkins, G., Howie, D., & Findlay, D. (2001). The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis. Journal of Bone and Joint Surgery-British Volume, 83B(6), 902-911.
DOI Scopus167 WoS137 Europe PMC101 |
| 2001 |
Fazzalari, N., Kuliwaba, J., Atkins, G., Forwood, M., & Findlay, D. (2001). The ratio of messenger RNA levels of receptor activator of nuclear factor kB ligand to osteoprotegerin correlates with bone remodeling indices in normal human cancellous bone but not in osteoarthritis. Journal of Bone and Mineral Research, 16(6), 1015-1027.
DOI Scopus118 WoS101 Europe PMC81 |
| 2001 |
Evdokiou, A., Atkins, G., Bouralexis, S., Hay, S., Raggatt, L., Cowled, P., . . . Findlay, D. (2001). Expression of alternatively-spliced MDM2 transcripts in giant cell tumours of bone. International Journal of Oncology, 19(3), 625-632.
DOI Scopus23 WoS22 Europe PMC15 |
| 2001 |
Atkins, G., Bouralexis, S., Haynes, D., Graves, S., Geary, S., Evdokiou, A., . . . Findlay, D. (2001). Osteoprotegerin inhibits osteoclast formation and bone resorbing activity in giant cell tumors of bone. Bone, 28(4), 370-377.
DOI Scopus86 WoS82 Europe PMC55 |
| 2001 |
Fazzalari, N., Kuliwaba, J., Atkins, G., Forwood, M., & Findlay, D. (2001). Osteoclast differentiation factor is dominant in controlling the extent of bone resorption. Bone, 28(5), S160.
DOI |
| 2001 |
Findlay, D., Bouralexis, S., Atkins, G., Chai, F., Hay, S., Clayer, M., & Evdokiou, A. (2001). Protection of normal human bone cells from Apo2L/TRAIL and chemotherapeutic drug combination-induced apoptosis. Bone, 28(5), S137.
DOI |
| 2001 |
Atkins, G., Evdokiou, A., Bouralexis, S., Chai, F., Hay, S., Clayer, M., & Findlay, D. (2001). Chemotherapeutic drugs sensitise osteogenic sarcoma cells but not normal human bone cells to TRAIL-mediated apoptosis. Bone, 28(5), S82. |
| 2001 |
Clayer, M., Bouralexis, S., Evdokiou, A., Hay, S., Atkins, G., & Findlay, D. (2001). Enhanced apoptosis of soft tissue sarcoma cells with chemotherapy: A potential new approach using TRAIL. Journal of Orthopaedic Surgery, 9(2), 19-22.
DOI Scopus18 Europe PMC10 |
| 2000 |
Atkins, G., Haynes, D., Graves, S., Evdokiou, A., Hay, S., Bouralexis, S., & Findlay, D. (2000). Expression of osteoclast differentiation signals by stromal elements of giant cell tumors. Journal of Bone and Mineral Research, 15(4), 640-649.
DOI Scopus162 WoS163 Europe PMC114 |
| 2000 |
Kitahama, S., Gibson, M., Hatzinikolas, G., Hay, S., Kuliwaba, J., Evdokiou, A., . . . Findlay, D. (2000). Expression of fibrillins and other microfibril-associated proteins in human bone and osteoblast-like cells. Bone, 27(1), 61-67.
DOI Scopus57 WoS53 Europe PMC34 |
| 2000 |
Findlay, D., Atkins, G., Forwood, M., Kuliwaba, J., & Fazzalari, N. (2000). Enhanced expression of osteocalcin mRNA in human osteoarthritic trabecular bone of the proximal femur is associated with decreased expression of interleukin-6 and interleukin-11 mRNA. Journal of Bone and Mineral Research, 15(2), 332-341.
DOI Scopus46 WoS43 Europe PMC36 |
| 2000 |
Atkins, G., Haynes, D., Geary, S., Loric, M., Crotti, T., & Findlay, D. (2000). Coordinated cytokine expression by stromal and hematopoietic cells during human osteoclast formation. Bone, 26(6), 653-661.
DOI Scopus69 WoS65 Europe PMC43 |
| 2000 |
Kuliwaba, J. S., Findlay, D. M., Atkins, G. J., Forwood, M. R., & Fazzalari, N. L. (2000). A molecular histomorphometric study of osteoarthritic cancellous bone. JOURNAL OF BONE AND MINERAL RESEARCH, 15(4), 811. |
| 2000 |
Findlay, D. M., Bouralexis, S., Atkins, G. J., Hedi, L., Hay, S., & Evdokiou, A. (2000). TRAIL-induced apoptosis of osteogenic sarcoma and breast cancer cells.. JOURNAL OF BONE AND MINERAL RESEARCH, 15, S352. |
| 1999 |
Atkins, G. J., Haynes, D. R., Graves, S. E., Evdokiou, A., Hay, S., Bouralexis, S., . . . Findlay, D. M. (1999). Expression of osteoclast differentiation signals by stromal elements of giant cell tumours.. JOURNAL OF BONE AND MINERAL RESEARCH, 14, S176.
WoS1 |
| 1999 |
Evdokiou, A., Atkins, G. J., Bouralexis, S., Hay, S. J., Raggatt, L. J., & Graves, S. E. (1999). Differential expression of MDM2 splice variants in bone tumors. MOLECULAR BIOLOGY OF THE CELL, 10, 428A. |
| 1999 |
Kuliwaba, J. S., Findlay, D. M., Atkins, G. J., Forwood, M. R., & Fazzalari, N. L. (1999). Bone remodelling in osteoarthritic cancellous bone a molecular histomorphometric study.. JOURNAL OF BONE AND MINERAL RESEARCH, 14, S464. |
| 1999 |
Evdokiou, A., Raggatt, L., Findlay, D., & Atkins, G. (1999). Calcitonin Receptor-Mediated Growth Suppression of HEK-293 Cells is Accompanied by Induction of p21 WAF1/CIP1 and G2/M Arrest. Molecular Endocrinology, 13(10), 1738-1750.
DOI Scopus38 WoS34 Europe PMC21 |
| 1999 |
Haynes, D., Atkins, G., Loric, M., Crotti, T., Geary, S., & Findlay, D. (1999). Bidirectional signaling between stromal and hemopoietic cells regulates interleukin-1 expression during human osteoclast formation. Bone, 25(3), 269-278.
DOI Scopus40 WoS34 Europe PMC25 |
| 1998 |
Evdokiou, A., Raggatt, L., Atkins, G. J., & Findlay, D. M. (1998). Growth inhibition by calcitonin of HEK293 cells is accompanied by induction of p21/WAF1/CIP1 and G2/M arrest. MOLECULAR BIOLOGY OF THE CELL, 9, 484A. |
| 1997 |
Atkins, G., Qiao, M., Coombe, D., Gowans, E., & Ashman, L. (1997). Hepatitis B virus binding to leucocyte plasma membranes utilizes a different region of the preS1 domain to the hepatocyte receptor binding site and does not require receptors for opsonins.. Immunology and Cell Biology, 75(3), 259-266.
DOI Scopus3 WoS1 |
| - |
Findlay, D. M., & Atkins, G. J. (n.d.). Mammals and minerals: a story of lactation and lacunae. IBMS BoneKEy, 9.
DOI |
